Iovance Biotherapeutics
IOVA
#2654
Rank
โ‚น622.08 B
Marketcap
โ‚น1,373
Share price
-0.45%
Change (1 day)
622.83%
Change (1 year)

Market capitalization of Iovance Biotherapeutics (IOVA)

Market cap: โ‚น622.08 Billion

As of October 2026 Iovance Biotherapeutics has a market cap of โ‚น622.08 Billion. This makes Iovance Biotherapeutics the world's 2654th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Iovance Biotherapeutics from 2010 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น622.08 B516.21%
2025โ‚น100.95 B-47.9%
2024โ‚น193.78 B11.88%
2023โ‚น173.20 B107.58%
2022โ‚น83.44 B-62.57%
2021โ‚น222.93 B-55.21%
2020โ‚น497.77 B99.49%
2019โ‚น249.52 B226.72%
2018โ‚น76.37 B105.85%
2017โ‚น37.10 B26.29%
2016โ‚น29.37 B17.95%
2015โ‚น24.90 B47.95%
2014โ‚น16.83 B29.6%
2013โ‚น12.98 B1223.59%
2012โ‚น0.98 B-76.52%
2011โ‚น4.17 B5.53%
2010โ‚น3.95 B

End of Day market cap according to different sources

On Oct 13th, 2026 the market cap of Iovance Biotherapeutics was reported to be:

โ‚น624.88 Billion
by Nasdaq info icon info icon
โ‚น624.88 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Nymox Pharmaceutical
NYMX
โ‚น1.73 B-99.72% Bahamas
NRC Health
NRC
โ‚น42.86 B-93.11%๐Ÿ‡บ๐Ÿ‡ธ USA